Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra



Kearsley-Fleet, Lianne, Beresford, Michael W ORCID: 0000-0002-5400-9911, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L and Dis, Biologics Children Rheumatic
(2019) Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra. RHEUMATOLOGY, 58 (1). 94 - 102.

[img] Text
Short-Term Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis Treated with either Tocilizumab or Anakinra.docx - Accepted Version

Download (308kB)
Item Type: Article
Uncontrolled Keywords: JIA, biologic therapies, epidemiology, outcome measures, statistics
Depositing User: Symplectic Admin
Date Deposited: 11 Sep 2018 14:38
Last Modified: 27 Dec 2019 13:10
DOI: 10.1093/rheumatology/key262
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3026118